I am a molecular microbiologist and cell biologist with broad experience in clinical and experimental microbiology and cell biology. I started my professional and scientific career in clinical and experimental microbiology. The first period was in clinical microbiology, which allowed me to gain practical experience in microbial diagnostics, including clinical specimen processing to determine the cause of infection. The next period involved microbial epidemiology, which involved investigating the spread of multidrug-resistant strains of Staphylococcus aureus, such as MRSA (methicillin-resistant Staphylococcus aureus), using molecular biology methods. Since 2009, I have been involved in molecular biomarker research related to the detection of energy metabolism changes in HD patients to find effective neuroprotection and optimization of metabolic impairment. In recent years, I have started a project related to host-pathogen interaction evaluation to find the cellular response of human cells derived from HD patients after S. aureus and Mycoplasma spp. influence on energy metabolism. During this part of the study, I developed some methods that can be used in microbial diagnostics and molecular biomarker studies. I am interested in the development of biomarkers for better identification of chronic infectious diseases.